Page 38 of 39 · 913 questions tagged clinical-trials.
Details up front: STEP 3 · retatrutide. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone else’s…
I have three data points across nine months, which I hope is enough to see a trend. This is presented as though it settles something, and I am not convinced it does.…
Conditions: REDEFINE-1 · liraglutide. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single result,…
Conditions: REDEFINE-1 · oral semaglutide. I want to know whether there is evidence behind this or only repetition. I have checked the obvious registries and…
For reference: SURMOUNT-1 · survodutide. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am reasonably…
What I am working with: dulaglutide · STEP 3. I keep seeing this stated as a fact with no explanation attached, and unexplained facts make me suspicious. My…
I have three data points across nine months, which I hope is enough to see a trend. I can do the algebra. I am not confident about the conversion factors. If there is…
The particulars: oral semaglutide · SURMOUNT-OSA. I would like the mechanism, because I want to be able to reason about the cases nobody has written about. I have…
For reference: oral semaglutide · TRIUMPH-3. I understand the observation; what I do not understand is the mechanism behind it. I have read the two review articles…
Concretely: constipation · oral semaglutide · SUSTAIN-6. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading…
Numbers first: mazdutide · SELECT. I can predict the outcome but I cannot explain it, which means I will get the next case wrong. I would like to know how confident…
What I am working with: PIONEER-1 · a GLP-1 receptor agonist. I would like help reading this properly rather than being told what conclusion to reach. I have the full…
Conditions: semaglutide · SURMOUNT-5. I want to know whether this is a real physical effect or an artefact of how it is measured. What prompted the question is an…
Concretely: PIONEER-4 · liraglutide. The claim is plausible, which is exactly why I want to check it. I am able to read a paper if someone points me at one. Has…
Stated plainly: 60 mg · cagrilintide. I would like to set this up properly once, rather than adjust it repeatedly. My budget is real but not tight, and my tolerance…
Concretely: 40 mg · oral semaglutide. I want to decide this in advance so that I am not deciding it under pressure later. Assume I will follow the plan I write down,…
The clinician who ordered the panel was not concerned; I would still like to understand it. This is one of those things that everyone repeats and nobody derives. This…
What I am working with: retatrutide · STEP 1. I keep seeing this stated as a fact with no explanation attached, and unexplained facts make me suspicious. My…
Concretely: TRIUMPH-1 · oral semaglutide. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single…
Setup, so nobody has to ask: SUSTAIN-6 · a GLP-1 receptor agonist. I have read the primary source rather than the summary, which has left me with more questions. I…
Conditions: 2.5 mg · oral semaglutide. The failure mode I am trying to avoid is making this decision emotionally. I have twelve months in view and I would like the…
The label documentation for the agent in question is ambiguous on exactly this point. The figures are clear enough; the question is what they mean and what they do…
What I am working with: SOUL · 15 mg. I would like help reading this properly rather than being told what conclusion to reach. I have the full report including the…
What I am working with: SURPASS-2 · mazdutide. I have read the primary source rather than the summary, which has left me with more questions. I understand the…